Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T23:44:51.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus

Published online by Cambridge University Press:  25 March 2010

N. Masurel ,
P. Ophof  and
P. de Jong
N. Masurel
Affiliation:
Department of Virology and WHO Influenza Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands
P. Ophof
Affiliation:
Regional Occupational Health Service for the Port Area and the District of Rotterdam, Rotterdam, The Netherlands
P. de Jong
Affiliation:
Dr Mr Willem van den Bergh Foundation, Noordwijk, The Netherlands
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A group of 269 pupils of the Harbour and Transport Training Institute in Rotterdam (group A), aged 13–20 years, and of 109 patients of the Dr Mr Willem van den Bergh Foundation at Noordwijk (group B), aged 11–21 years, were immunized with a whole virus vaccine containing 10, 20, or 40 μg HA of A/USSR/92/77 (H1N1) influenza virus. A booster vaccination was administered 6 weeks later with 20 μg HA of the same virus. Many of the participants had been immunized during the two preceding years with a whole virus vaccine containing A/New Jersey/8/76 (H1N1) (A/NJ/76) virus. The side-effects, mostly of a moderate nature, increased with the dose of virus in the vaccine. In group A side effects were least frequent in the vaccinees who had never received A/NJ/76 vaccine. A single dose of A/USSR/77 vaccine did not produce satisfactory levels of homologous antibodies. After booster immunization with 20 μg HA of A/USSR/77 virus participants showed a higher homologous antibody response in all vaccine-dose groups if they had not been immunized with A/NJ/76 virus in previous years. After primary and especially after booster immunization with A/USSR/77 virus, a very high response against A/NJ/76 virus and adequate levels of A/NJ/76 antibody were found in participants who had been immunized previously with A/NJ/76 virus. Those who had not been immunized with this virus previously showed no or a very low antibody response to A/NJ/76 virus.

Type
Research Article
Information
Journal of Hygiene , Volume 87 , Issue 2 , October 1981 , pp. 201 - 209
Copyright
Copyright © Cambridge University Press 1981

References

Davenport, F. M. & Hennessy, A. V. (1956). A serologie recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. Journal of Experimental Medicine 104, 85.CrossRefGoogle Scholar
Davenport, F. M., Hennessy, A. V. & Francis, T. (1953). Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. Journal of Experimental Medicine 98, 641.CrossRefGoogle ScholarPubMed
Feery, B. J., Gallichio, H. A., Rodda, S. J. & Hampson, A. W. (1979). Antibody responses to influenza vaccines containing A/USSR/90/77. Australian Journal of Experimental Biology and Medical Sciences 57, 335.CrossRefGoogle ScholarPubMed
Francis, T. (1955). The current status of the control of influenza. Annals of Internal Medicine 43, 534.Google ScholarPubMed
Gross, P. A., Ennis, F. A., Gaerlan, P. F., Denson, L. J., Denning, C. R. & Schiffman, D. (1977). A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. Journal of Infectious Diseases 136, 623.CrossRefGoogle ScholarPubMed
Hoskins, T. W., Davies, J. R., Smith, A. J., Miller, C. L. & Allchin, A. (1979). Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet I, 33.CrossRefGoogle Scholar
Laver, W. G., Downie, J. C. & Webster, R. G. (1976). Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses. Journal of Immunology 116, 336.CrossRefGoogle Scholar
Masurel, N. (1962). Studies on the content of haemagglutination inhibiting antibody for swine influenza virus A in sera from people living in The Netherlands in 1957–1958. Thesis, University of Leiden.Google Scholar
Masurel, N. (1969). Relation between Hong Kong virus and former human A2 isolates and the A/Equi2 virus in human sera collected before 1957. Lancet I, 907.CrossRefGoogle Scholar
Masurel, N. (1976). Swine influenza virus and the recycling of influenza-A viruses in man. Lancet II 244.CrossRefGoogle Scholar
Masurel, N. (1979). Immunization of aged subjects with subunit and total virus vaccine containing H1N1 influenza virus. Nederlands Tijdschrift voor Geneeskunde 123, 196.Google Scholar
Masurel, N. & André, F. E. (1978). Antibody response against current H1N1 influenza virus after vaccination with last season's trivalent vaccine. Lancet I, 144.Google Scholar
Masurel, N., de Jong, P. & Verhoeff, W. F. K. (1977). Vaccination of a group of young people with influenza virus A/New Jersey/1976 (Hsw1N1). Nederlands Tijdschrift voor Geneeskunde 121, 1800.Google Scholar
Nicholson, K. G., Tyrrell, D. A. J., Harrison, P., Potter, C. W., Jennings, R., Clark, A., Schild, G. C., Wood, J. M., Yetts, R., Seagrgatt, V., Huggins, A. & Anderson, S. G. (1979). Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. Journal of Biological Standardization 7, 123.CrossRefGoogle ScholarPubMed
Potter, C. W., Clark, A., Jennings, R., Schild, G. C., Wood, J. M. & McWilliam, P. K. A. (1980). Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. Journal of Biological Standardization 8, 35.CrossRefGoogle Scholar
Virelizier, J. L., Allison, A. C. & Schild, G. C. (1974). Antibody response to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone-marrow derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. Journal of Experimental Medicine 140, 1571.CrossRefGoogle Scholar
Wesselius-de Casparis, A., Masurel, N. & Kerrebijn, K. F. (1972). Field trial with human and equine influenza vaccines in children: protection and antibody titres. Bulletin of the World Health Organization 46, 151.Google Scholar